STEMSAFE
LIVE

Serial Number

79315374

Owner

STEMFORM A/S

Attorney

Elizabeth A. Cominolli

Filing Date

May 12, 2021

Add to watchlist:

No watchlists yet
View on USPTO

STEMSAFE Trademark

Serial Number: 79315374 • Registration: 6854558

STEMSAFE is a trademark filed by STEMFORM A/S on May 12, 2021. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

STEMFORM A/S (4 trademarks)

c/o Aleris Hamlet,

Entity Type: 99

Trademark Details

Filing Date

May 12, 2021

Registration Date

September 27, 2022

Published for Opposition

July 12, 2022

Goods & Services

Surgical apparatus and instruments; medical apparatus and instruments for use in cosmetic treatment; medical apparatus, namely, apparatus for the regeneration of stem cells for medical purposes; artificial limbs, eyes and teeth; suture materials; massage apparatus; implant consisting of artificial materials for use in surgery; Surgical and wound treating equipment, namely, electronic medical appliances for wound healing; Surgical implants comprised of artificial materials; Artificial skin for surgical purposes; Apparatus for the regeneration of stem cells for medical purposes

Medical services; veterinary services; hygienic and beauty care for human beings or animals; Physician services; Medical assistance; Hospital services; Medical clinic services; Surgery; Conducting medical examinations; Medical treatment services using cultured cells; Hygienic and beauty care; Nursing, medical; Medical analysis services relating to the treatment of patients; Cosmetic and plastic surgery; Human tissue bank services; Stem cell therapy services; Stem cell storage, namely, isolation, collection, and banking of umbilical cord tissue perivascular stem cells; Medical services relating to the removal, treatment and processing of stem cells

Pharmaceuticals for the treatment of heart conditions and cardiovascular conditions; Pharmaceuticals for the treatment of arthritis; Pharmaceuticals for the treatment of neurological diseases; Pharmaceuticals for the treatment of diabetes; Pharmaceuticals for the treatment of inflammatory bowel diseases; Pharmaceuticals for the treatment of wounds; sanitary preparations for medical purposes; medical plasters, materials for dressings, namely, gauze and wadding; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides; Biotechnological preparations for medical use for the treatment of heart conditions and cardiovascular conditions; Biotechnological preparations for medical use for the treatment of arthritis; Biotechnological preparations for medical use for the treatment of neurological diseases; Biotechnological preparations for medical use for the treatment of diabetes; Biotechnological preparations for medical use for the treatment of inflammatory bowel diseases; Biotechnological preparations for medical use for the treatment of wounds; implants comprising live organs and tissues for surgical purpose; Surgical implants comprised of living tissues grown from stem cells; Biological tissue grafts for implantation; Tissue-regenerative pharmaceutical preparations for the treatment of wounds; Stem cells for medical or veterinary use; Pharmaceutical preparations containing stem cells for the treatment of heart conditions and cardiovascular conditions; Pharmaceutical preparations containing stem cells for the treatment of arthritis; Pharmaceutical preparations containing stem cells for the treatment of neurological diseases; Pharmaceutical preparations containing stem cells for the treatment of diabetes; Pharmaceutical preparations containing stem cells for the treatment of inflammatory bowel diseases; Pharmaceutical preparations containing stem cells for the treatment of wounds

Scientific and technological services, namely, stem cell research services; scientific and technological services, namely, scientific analysis and testing in the field of stem cell technology and research and design related thereto; scientific industrial analysis and industrial research services in the field of stem cell technology; design and development of computer hardware and software; Biological analysis; Chemical analysis; Bacteriological research; Biological research; Medical research; Research and development of new products for others; Chemical research; Quality control for others; Biotechnology research; Consultancy in the field of biotechnology; Information on the subject of scientific research in the field of biochemistry and biotechnology; biological tissue engineering

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Oct 30, 2025 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Feb 14, 2023 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jan 23, 2023 FICS
FINAL DISPOSITION PROCESSED
Jan 23, 2023 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Dec 27, 2022 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Sep 27, 2022 NRCC
REGISTERED-PRINCIPAL REGISTER
Sep 27, 2022 R.PR
NOTIFICATION PROCESSED BY IB
Jul 18, 2022 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 12, 2022 NPUB
PUBLISHED FOR OPPOSITION
Jul 12, 2022 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jun 29, 2022 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jun 29, 2022 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 22, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 7, 2022 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 4, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 3, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 3, 2022 TROA
REFUSAL PROCESSED BY IB
Feb 28, 2022 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Feb 10, 2022 RFCS
REFUSAL PROCESSED BY MPU
Feb 10, 2022 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jan 22, 2022 RFCR
NON-FINAL ACTION WRITTEN
Jan 21, 2022 CNRT
ASSIGNED TO EXAMINER
Jan 20, 2022 DOCK
APPLICATION FILING RECEIPT MAILED
Jul 20, 2021 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 16, 2021 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jul 15, 2021 REPR